Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Social Psychiatry and Psychiatric Epidemiology
Erschienen in: Social Psychiatry and Psychiatric Epidemiology 11/2007

01.11.2007 | ORIGINAL PAPER

Patients’ perspectives on what works in psychoeducational groups for schizophrenia

A qualitative study

verfasst von: Ingrid Sibitz, Michaela Amering, MD, Ralf Gössler, Annemarie Unger, Heinz Katschnig

Erschienen in: Social Psychiatry and Psychiatric Epidemiology | Ausgabe 11/2007

Einloggen, um Zugang zu erhalten

Abstract

Background

Psychoeducational groups are a common component of interventions in schizophrenia.

Aims

To explore patients’ views about wanted and unwanted effects of group psychoeducation.

Method

Subjective feedback of 103 participants of a psychoeducational intervention as well as data from two specific focus groups—one with “enthusiastic” and one with “critical” participants—were analyzed by means of qualitative content analysis.

Results

Participants emphasized the importance of information received and of exchanging information with others suffering from the same disorder. Positive effects on coping, activation and social interaction were reported. Perceived overemphasis on illness related information produced defensive reactions, whereas the integration of quality of life topics was appreciated. A pleasant group atmosphere and clinical stability were suggested as important determinants of success.

Conclusions

Qualitative analyzses of participants’ views help to understand the potentials of a psychoeducational intervention in schizophrenia.
Literatur
1.
Amering A, Sibitz I, Gössler R, Katschnig H (2002) Wissen—genießen—besser leben. Ein Seminar für Menschen mit Psychoseerfahrung. Bonn, Psychiatrie-Verlag
2.
Amering A, Sibitz I, Gössler R, Katschnig H. Conoscere-godersi la vita e viver meglio. Un seminario per persone con esperienze di psicosi. Napoli, Idelson, in print
3.
Ascher-Svanum H, Krause AA (1991) Psychoeducational groups for patients with schizophrenia: a guide for practitioners. Gaithersburg, MD, US, Aspen Publishers
4.
Atkinson JM, Coia DA, Harper Gilmour H, Harper JP (1996) The impact of education groups for people with schizophrenia on social functioning and quality of life. Br J Psychiatry 168:199–204PubMedCrossRef
5.
Cohn RC (1992) Von der Psychoanalyse zur Themenzentrierten Interaktion, 11th edn. Stuttgart, Klett-Cotta
6.
Frisch MB (2005) Quality of life therapy: applying a life satisfaction approach to positive psychology and cognitive therapy. John Wiley & Sons, Chichester New York
7.
Hohmann AA, Shear MK (2002) Community-based intervention research: coping with the “noise” of real life in study design. Am J Psychiatry 159:201–207PubMedCrossRef
8.
Hornung WP, Klingberg S, Feldmann R, Schonauer K, Schulze Monking H (1998) Collaboration with drug treatment by schizophrenic patients with and without psychoeducational training: results of a 1-year follow-up. Acta Psychiatr Scand 97:213–219PubMedCrossRef
9.
Huberman AM, Miles MB (1994) Data management and analysis methods. In: Denzin NK, Lincoln YS (eds) Handbook of qualitative research. Sage Publications, Thousand Oaks, London, New Delhi
10.
Janè-Llopis E, Katschnig H (2006) Improving quality of life through mental health promotion. In: Katschnig H, Freeman H, Sartorius N (eds) Quality of life in mental disorders, 2nd edn. John Wiley & Sons, Chichester New York
11.
Jones PB, Barnes TRE, Davies L, Dunn G, Lloyd H, Hayhurst KP, Murray RM, Markwick A, Lewis SW (2006) Randomized controlled trial of the effect on quality of life of second- versus first-generation antipsychotic drugs in schizophrenia: cost utility of the latest antipsychotic drugs in schizophrenia study (CUtLASS 1). Arch Gen Psychiatry 63:1079–1087PubMedCrossRef
12.
Katschnig H, Freeman H, Sartorius N (2006) Quality of life in mental disorders, 2nd edn. John Wiley & Sons, Chichester New York
13.
Katschnig H, Konieczna T (1998) What works in work with relatives? A hypothesis. Br J Psychiatry 155(Suppl 5):144–150
14.
Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13(2):261–276PubMed
15.
Kilian R, Lindenbach I, Angermeyer MC (2001) “(...) sometimes I have doubts about myself, when I’m not doing well.” Effect of an ambulatory psychoeducational group program from the subjective perspective of patients with schizophrenic illnesses. Psychiatr Prax 28:168–173PubMedCrossRef
16.
Lambert M, Schimmelmann BG, Naber D, Schacht A, Karow A, Wagner T, Czekalla J (2006) Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia. J Clin Psychiatry 67:1690–1697PubMedCrossRef
17.
Lieberman JA, Stroup TS, McEvoy J, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353(12):1209–1223PubMedCrossRef
18.
Mayer RE (2004) Should there be a three-strikes rule against pure discovery learning? Am Psychol 59:14–19PubMedCrossRef
19.
McIntosh AM, Harrison LK, Forrester K, Lawrie SM, Johnstone EC (2005) Neuropsychological impairments in people with schizophrenia or bipolar disorder and their unaffected relatives. Br J Psychiatry 186:378–385PubMedCrossRef
20.
Morgan D (1997) Focus groups as qualitative research. Sage Publications, Thousand Oaks, London, New Delhi
21.
Mueser KT, Corrigan PW, Hilton DW, Tanzman B, Schaub A, Gingerich S, Essock SM, Tarrier N, Morey B, Vogel-Scibilia S, Herz MI (2002) Illness management and recovery: a review of the research. Psychiatr Serv 53:1272–1284PubMedCrossRef
22.
Muir Gray JM (2001) Evidence-based healthcare, 2nd edn. Churchill Livingstone, London
23.
24.
Paley G, Shapiro DA (2002) Lessons from psychotherapy research for psychological interventions for people with schizophrenia. Psychol Psychother Theory Res Pract 75:5–17CrossRef
25.
Pekkala E, Merinder L (2002) Psychoeducation for schizophrenia. Cochrane Database Syst Rev CD002831
26.
Penn DL, Waldheter EJ, Perkins DO, Mueser KT, Lieberman JA (2005) Psychosocial treatment for first-episode psychosis: a research update. Am J Psychiatry 162:2220–2232PubMedCrossRef
27.
Pfammatter M, Junghan UM, Brenner HD (2006) Efficacy of psychological therapy in schizophrenia: conclusions from meta-analyses. Schizophrenia Bull 32(Suppl 1):S64–S80CrossRef
28.
Pharoah F, Mari J, Rathbone J, Wong W (2006) Family intervention for schizophrenia. Cochrane Database Syst Rev 18(4):CD000088
29.
Pilling S, Bebbington P, Kuipers E, Garety P, Geddes J, Orbach G, Morgan C (2002) Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy. Psychol Med 32(5):763–782PubMedCrossRef
30.
Pitschel-Walz G, Bäuml J, Bender W, Engel RR, Wagner M, Kissling W (2006) Psychoeducation and compliance in the treatment of schizophrenia: results of the Munich psychosis information project study. J Clin Psychiatry 67:443–452PubMed
31.
Resnick SG, Rosenheck RA, Lehman AF (2004) An exploratory analysis of correlates of recovery. Psychiat Serv 55:540–547CrossRef
32.
Roick C, Fritz-Wieacker A, Matschinger H, Heider D, Schindler J, Riedel-Heller S, Angermeyer MC (2007) Health habits of patients with schizophrenia. Soc Psychiatry Psychiatr Epidemiol 42:268–276PubMedCrossRef
33.
Rosenbaum B, Valbak K, Harder S, Knudsen P, Koster A, Lajer M, Lindhardt A, Winther G, Petersen L, Jorgensen P, Nordentoft M, Andreasen Ah (2005) The Danish National Schizophrenia Project: prospect, comparative longitudinal treatment study of first-episode psychosis. Br J Psychiatry 186:394–399PubMedCrossRef
34.
Rosenheck R, Cramer J, Xu W, Thomas J, Henderson W, Frisman L, Fye C, Charney D (1997) A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. N Engl J Med 337:809–815PubMedCrossRef
35.
Rummel CB, Hansen WP, Helbig A, Pitschel-Walz G, Kissling W (2005) Peer-to-peer psychoeducation in schizophrenia: a new approach. J Clin Psychiatry 66:1580–1585PubMedCrossRef
36.
Samele C, Patel M, Boydell J, Leese M, Wessely S, Murray R (2007) Physical illness and liefestyle risk factors in people with their first presentation of psychiosis. Soc Psychiatry Psychiatr Epidemiol 42:117–124PubMedCrossRef
37.
Schaub A, Andres K, Brenner HD, Donzel G (1997) Developing a group format coping-orientated treatment programme for schizophrenic patients. In: Böker W, Brenner HD, Genner R (eds) Towards a comprehensive therapy for schizophrenia. Hogrefe and Huber, Seattle pp 228–251
38.
Sibitz I, Katschnig H, Gössler R, Amering M (2006) “Knowing—enjoying—living better”—A seminar for persons with psychosis to improve their quality of life and reduce their vulnerability. A preliminary report. Psychol Prax 33:170–176
39.
Sibitz I, Amering M, Gössler R, Unger A, Katschnig H (2007) One year outcome of low intensity booster sessions versus care as usual in psychosis patients after a short term psychoeducational intervention. Eur Psychiatry 22:203–210PubMedCrossRef
40.
Szmidla A, Leff J (2006) Differentiating the effects of pharmacological and psychosocial interventions in an intensive rehabilitation programme. Soc Psychiaty Psychiatr Epidemiol 41:734–737CrossRef
41.
Wagner LC, King M (2005) Existential needs of people with psychotic disorders in Porto Alegre, Brazil. Br J Psychiatry 186:141–145PubMedCrossRef
42.
Yalom ID (1985) The theory and practice of group psychotherapy. Basic Books, Inc, New York
43.
Zygmunt A, Olfson M, Boyer CA, Mechanic D (2002) Interventions to improve medication adherence in schizophrenia. Am J Psychiatry 159:1653–1664PubMedCrossRef
Metadaten
Titel
Patients’ perspectives on what works in psychoeducational groups for schizophrenia
A qualitative study
verfasst von
Ingrid Sibitz
Michaela Amering, MD
Ralf Gössler
Annemarie Unger
Heinz Katschnig
Publikationsdatum
01.11.2007
Verlag
D. Steinkopff-Verlag
Erschienen in
Social Psychiatry and Psychiatric Epidemiology / Ausgabe 11/2007
Print ISSN: 0933-7954
Elektronische ISSN: 1433-9285
DOI
https://doi.org/10.1007/s00127-007-0245-5

Weitere Artikel der Ausgabe 11/2007

Social Psychiatry and Psychiatric Epidemiology 11/2007 Zur Ausgabe

ORIGINAL PAPER

Doctors’ attitude towards people with mental illness in Western Nigeria

ORIGINAL PAPER

Visual impairment in persons with psychotic disorder

ORIGINAL PAPER

Risk of readmission in compulsorily and voluntarily admitted patients

ORIGINAL PAPER

Caregiver burden and coping

ORIGINAL PAPER

Childhood trauma history and dissociative experiences among Turkish men diagnosed with antisocial personality disorder

ORIGINAL PAPER

Prevalence of pseudoneurologic conversion disorder in an urban community in Manisa, Turkey

Neu im Fachgebiet Psychiatrie

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise